Asking More of
Medicine
“If macular degeneration were a country, it would be the eighth-most populated nation in the world,” said UVA’s Dr. Jayakrishna Ambati. Put plainly, macular degeneration means hundreds of millions of people are at risk of going blind.
Through collaboration, Dr. Ambati and his team found that macular degeneration patients have an excess of Alu, a toxic molecule similar to HIV. Testing antiretrovirals – a drug already approved for the treatment of HIV and AIDS – they discovered an interruption in the progress of macular degeneration models. Which led them to ask a question: Could antiretrovirals affect other aging diseases?
Asking More of
Big Data
While their effects vary, macular degeneration, atherosclerosis and Alzheimer’s share similar, underlying traits. Agitated by weaker and older immune systems, these diseases are each driven by inflammasomes.
Collaborating with UVA computer scientists, Dr. Ambati and his team conducted big data archeology. Mining large health insurance databases, they discovered that patients on anti-HIV drugs were protected from these inflammatory diseases to a dramatic extent. The implications of this discovery are staggering.